Helen Yeoman

Helen Yeoman is a seasoned biologist with extensive experience in the pharmaceutical and biotechnology sectors. Currently serving as a Senior Biologist at Reglagene since 2021, Helen previously held leadership positions as a Lead Research Investigator and Group Leader at Icagen and Sanofi from 2016 to 2020 and 2004 to 2016, respectively. Helen's career also includes notable roles at Aventis Pharmaceuticals, Hoechst Marion Roussel Inc., Marion Merrel Dow, and Selectide Corporation, accumulating rich expertise in research and development. Helen's academic credentials include a PhD in Cancer Immunology from the University of Nottingham, alongside multiple postdoctoral fellowships in Immunology from prestigious institutions such as the University of Cambridge, the National Institute for Medical Research, and the University of Arizona, complemented by a Master's in Immunology from the University of Birmingham and a Bachelor's in Microbiology from the University of Kent.